An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder

Clinical trial NCT00266747 · COMPLETED

Trial details

NCT number: NCT00266747
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2005-12-01
Primary completion: 2007-01-01
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.